Status:
RECRUITING
StereoTactic Ablative RadioTherapy of Cardiac Arrhythmias (START-CA)
Lead Sponsor:
University Health Network, Toronto
Conditions:
Cardiac Arrhythmia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a prospective, single-center, phase II trial that will be monitoring the safety and efficacy of using stereotactic ablative radiotherapy (SBRT) to treat patients with a medical condition affec...
Eligibility Criteria
Inclusion
- Patients with heart rate and rhythm condition (arrhythmia) who have failed standard of care treatment with medication OR at least one prior invasive catheter ablation procedure.
- Patients deemed medically fit to receive stereotactic ablative radiotherapy as determined by their Radiation Oncologist.
Exclusion
- Patients who have previously received high dose radiotherapy to the target area and cannot safely receive further treatment OR are unable to receive radiotherapy due to other contraindications.
Key Trial Info
Start Date :
December 14 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04843683
Start Date
December 14 2021
End Date
December 1 2027
Last Update
February 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Princess Margaret Cancer Center, University Health Network
Toronto, Ontario, Canada, M5G 2M9